Portfolio (Quarterly)
Guide ↗
Atle Fund Management AB
· CIK 0001381843| # | Ticker | Company | Sector | Shares | Value ↓ | % Port | Chg Shares | Chg % | Period Price ① | Since Period ① |
|---|---|---|---|---|---|---|---|---|---|---|
| 21 | — | NEWAMSTERDAM PHARMA CO NV | — | 248,848.0 | $8.4M | 2.27% | NEW | — | $33.89 | — |
| 22 | ABVX | ABIVAX SA | Healthcare | 58,170.0 | $7.8M | 2.08% | NEW | — | $133.26 | -14.9% |
| 23 | INCY | INCYTE CORP | Healthcare | 56,953.0 | $6.5M | 1.74% | NEW | — | $113.36 | +9.7% |
| 24 | IRTC | IRHYTHM TECHNOLOGIES INC | Healthcare | 54,102.0 | $6.4M | 1.73% | NEW | — | $118.95 | +1.1% |
| 25 | BSX | BOSTON SCIENTIFC | Healthcare | 146,381.0 | $6.2M | 1.68% | NEW | — | $42.68 | +9.7% |
| 26 | INSM | INSMED INC | Healthcare | 58,378.0 | $6.2M | 1.68% | NEW | — | $106.62 | +11.2% |
| 27 | TNGX | TANGO THERAPEUTICS INC | Healthcare | 198,557.0 | $6.2M | 1.67% | NEW | — | $31.26 | -25.3% |
| 28 | GILD | GILEAD SCIENCES INC | Healthcare | 46,142.0 | $5.8M | 1.57% | NEW | — | $126.34 | +15.3% |
| 29 | CAH | CARDINAL HEALTH INC | Healthcare | 23,630.0 | $5.6M | 1.51% | NEW | — | $237.56 | -1.3% |
| 30 | ORKA | ORUKA THERAPEUTI | Healthcare | 54,886.0 | $5.2M | 1.41% | NEW | — | $95.17 | -4.2% |
| 31 | SYRE | SPYRE THERAPEUTICS INC | Healthcare | 57,030.0 | $5.1M | 1.36% | NEW | — | $88.78 | +1.8% |
| 32 | DXCM | DEXCOM INC | Healthcare | 71,846.0 | $4.8M | 1.30% | NEW | — | $67.35 | +34.8% |
| 33 | BCAX | BICARA THERAPEUTICS INC | Healthcare | 145,657.0 | $4.3M | 1.16% | NEW | — | $29.69 | -21.1% |
| 34 | IDYA | IDEAYA BIOSCIENCES INC | Healthcare | 94,478.0 | $3.5M | 0.95% | NEW | — | $37.27 | +7.6% |
| 35 | CELC | CELCUITY INC | Healthcare | 33,313.0 | $3.5M | 0.94% | NEW | — | $104.62 | -15.5% |
| 36 | — | DISC MEDICINE INC | — | 43,682.0 | $3.2M | 0.86% | NEW | — | $73.14 | — |
| 37 | PYXS | PYXIS ONCOLOGY INC | Healthcare | 966,459.0 | $2.9M | 0.78% | NEW | — | $3.01 | +7.3% |
| 38 | CMPX | COMPASS THERAPEUTICS INC | Healthcare | 1,048,593.0 | $2.3M | 0.62% | NEW | — | $2.19 | +9.6% |
| 39 | JBIO | JADE BIOSCIENCES | Healthcare | 88,556.0 | $2.0M | 0.53% | NEW | — | $22.22 | -6.2% |
① Period Price is the implied market price on the last day of the reporting period, calculated as reported value ÷ shares held. It is not the fund's purchase price or cost basis — the fund may have initiated or added to the position at any point during the quarter at a different price. Since Period shows the price change from that quarter-end snapshot to today's last price — it reflects stock movement after the report date, not the fund's actual return.
Sector Allocation
Healthcare
100.0%